Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Clinical study on the efficacy and safety of glaucoma drainage implants in the treatment of different types of glaucoma].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2024

Same author

Posttraumatic Stress, Anxiety, and Depression in COVID-19 Survivors.

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan·2022

Same author

Advances in biomaterials for skeletal muscle engineering and obstacles still to overcome.

Materials today. Bio·2020

Same author

Patients' Reports of Traumatic Experience and Posttraumatic Stress in Psychiatric Settings.

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan·2020

Same author

Modular, tissue-specific, and biodegradable hydrogel cross-linkers for tissue engineering.

Science advances·2019

Same author

First Report of Paulownia Witches'-Broom Phytoplasma in China.

Plant disease·2019

Same journal

Change in u.s. Patent infringement law.

Tissue engineering·2009

Same journal

Functional reconstruction of the jaw bones using poly(l-lactide) mesh and autogenic particulate cancellous bone and marrow.

Tissue engineering·2009

Same journal

Effect of the structure of bone morphogenetic protein carriers on ectopic bone regeneration.

Tissue engineering·2009

Same journal

Cross-linking of gelatin with carbodiimides.

Tissue engineering·2009

Same journal

Early treatment of diabetes with porcine islets in a bioartificial pancreas.

Tissue engineering·2009

Same journal

Permeability of filters used for immunoisolation.

Tissue engineering·2009

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

Cardiovascular gene transfer.

A D Ouellette¹, K K Wu, A G Mikos

¹Institute of Biosciences and Bioengineering, Department of Chemical Engineering, Rice University, P.O. Box 1892, Houston, Texas 77251.

Tissue Engineering

|November 3, 2009

Summary

This summary is machine-generated.

Gene delivery to the cardiovascular system shows promise for treating diseases. Current viral and non-viral vectors have limitations like toxicity and inconsistent gene expression, requiring further development for human application.

More Related Videos

In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium

In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium

Published on: May 6, 2018

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

Published on: April 16, 2018

Related Experiment Videos

Last Updated: Jun 19, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium

In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium

Published on: May 6, 2018

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

Published on: April 16, 2018

Area of Science:

Cardiovascular research
Gene therapy
Molecular medicine

Background:

The cardiovascular system offers a large surface area and direct blood access, making it an attractive target for gene delivery.
Existing gene transfer methods using adenoviral, retroviral vectors, and liposomes have shown feasibility in various cell types and animal models.

Purpose of the Study:

To review the current status and challenges of gene delivery to the cardiovascular system.
To identify areas for improvement in vector technology and delivery methods for clinical translation.

Main Methods:

Review of existing literature on gene transfer techniques in cardiovascular research.
Analysis of the efficacy, toxicity, and expression variability of current gene delivery vectors.
Identification of emerging strategies and future research directions.

Main Results:

Gene transfer into vascular cells has been achieved using viral vectors and liposomes in preclinical studies.
Current methods face challenges including vector toxicity and inconsistent gene expression levels.
Significant improvements are needed before these techniques can be safely and effectively applied in human patients.

Conclusions:

The cardiovascular system holds significant potential for gene therapy applications.
Overcoming current limitations in vector safety, efficiency, and gene expression is crucial for clinical success.
Development of next-generation viral vectors, novel lipid formulations, and advanced delivery systems is essential to advance cardiovascular gene therapy.